Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 11, 2025 16:05 ET | Source: Tianci International, Inc.

Tianci International, Inc. Announces Closing of $7 Million Public Offering

HONG KONG and RENO, Nev., April 11, 2025 (GLOBE NEWSWIRE) -- Tianci International, Inc. (the "Company” or “Tianci”), a global logistics service provider specializing in ocean freight forwarding,...
April 09, 2025 20:00 ET | Source: Tianci International, Inc.

Tianci International, Inc. Announces Nasdaq Uplisting and Pricing of $7 Million Public Offering

HONG KONG and RENO, Nev., April 09, 2025 (GLOBE NEWSWIRE) -- Tianci International, Inc. (the "Company” or “Tianci”), a global logistics service provider specializing in ocean freight forwarding,...
September 27, 2022 09:05 ET | Source: Silo Pharma, Inc.

Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock

ENGLEWOOD CLIFFS, NJ , Sept. 27, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (formerly OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional...
June 01, 2022 08:30 ET | Source: Correlate Infrastructure Partners, Inc.

Correlate Infrastructure Partners Inc. Announces Its Application to Uplist to the NASDAQ Exchange

BOISE, Idaho, June 01, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Correlate Infrastructure Partners Inc. (OTCQB: CIPI) (“Correlate” or the “Company”), a technology-enabled energy optimization and...
August 04, 2021 08:00 ET | Source: Worksport Ltd

Worksport Announces Nasdaq Uplisting in Connection with Public Offering

Vaughan, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Worksport Ltd. (Nasdaq-CM: WKSP; WKSPW) (or the “Company”), a developer and manufacturer of high quality, modular, and attractively priced tonneau covers,...
April 26, 2021 20:58 ET | Source: Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering

New York, April 26, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("PTIX" or "Company") today announced the pricing of an underwritten public offering of 3,180,000 units at a...